BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25583017)

  • 1. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
    Krook KA; Fedewa SA; Chen AY
    Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
    Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
    J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
    Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
    James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
    Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
    Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
    Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
    Randle RW; Balentine CJ; Leverson GE; Havlena JA; Sippel RS; Schneider DF; Pitt SC
    Surgery; 2017 Jan; 161(1):137-146. PubMed ID: 27842913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of extensive neck dissection on survival from papillary thyroid cancer.
    Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric papillary thyroid cancer >1 cm: is total thyroidectomy necessary?
    Nice T; Pasara S; Goldfarb M; Doski J; Goldin A; Gow KW; Nuchtern JG; Vasudevan SA; Langer M; Beierle EA
    J Pediatr Surg; 2015 Jun; 50(6):1009-13. PubMed ID: 25819020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.
    Hassan A; Razi M; Riaz S; Khalid M; Nawaz MK; Syed AA; Bashir H
    Clin Nucl Med; 2016 Aug; 41(8):606-13. PubMed ID: 27124680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
    Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
    Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
    PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.